The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly PatientsGlobeNewsWire • 01/04/22
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIMGlobeNewsWire • 11/22/21
Amryt Pharma (AMYT) CEO Dr. Joe Wiley on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/07/21
Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/21
Amryt Pharma third-quarter revenue up over 14% on soaring metreleptin salesProactive Investors • 11/03/21
Earnings Preview: Amryt Pharma PLC Sponsored ADR (AMYT) Q3 Earnings Expected to DeclineZacks Investment Research • 10/28/21
Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3GlobeNewsWire • 10/20/21
Amryt Pharma raises sales forecast again as acquisition makes strong startProactive Investors • 09/13/21
Amryt Pharma (AMYT) CEO Dr. Joe Wiley on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21